Alipour, R. http://orcid.org/0000-0002-1248-0967
Jackson, P.
Bressel, M.
Hogg, A.
Callahan, J.
Hicks, R. J.
Kong, G.
Funding for this research was provided by:
University of Melbourne
Article History
Received: 3 December 2022
Accepted: 30 April 2023
First Online: 15 May 2023
Declarations
:
: No: retrospective analysis.
: Human Research Ethics Committee (HREC) waiver obtained for the requirement of consent.
: Rodney J Hicks is a shareholder in Telix Pharmaceuticals and on the Scientific Advisory Board of Revela. He is the founder and part-owner of PreMIT Pty Ltd and Precision Molecular Imaging and Theranostics Pty Ltd. Other authors declare that they have no conflict of interest.